Mercer Global Advisors »

Lexeo Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $23k 4.9k 4.65

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding Lexeo Therapeutics

Suvretta Capital Management
Affinity Asset Advisors
BlackRock
RA Capital Management
Henderson Group
Frazier Life Sciences Management
Vestal Point Capital
Paradigm Biocapital Advisors
Jupiter Topco
OrbiMed Advisors
Citadel Advisors
State Street Corporation
Vanguard Capital Management
Millennium Management
Woodline Partners

View all funds holding Lexeo Therapeutics